Magdalena Corona

578 citations
18 papers · 182 indexed · h-index 6
Topics
CAR-T cell therapy research (7 papers)SARS-CoV-2 and COVID-19 Research (6 papers)COVID-19 Clinical Research Studies (6 papers)
Partner nations
SpainUnited StatesGreece

In The Last Decade

Magdalena Corona

16 papers receiving 181 citations

Peers

Magdalena Corona
Comparison fields: 5 of 40
  • Infectious Diseases 117
  • Oncology 101
  • Immunology 26
  • Neurology 22
  • Hematology 21
Replace Adolfo Sáez with:
Adolfo Sáez Spain
Fateeha Furqan United States
Juan Marquet Spain
Jenni Bloomquist United States
Sinem Namdaroğlu Türkiye
Mónica Duarte Colombia
Diane M. Del Valle United States
Kazimieras Maneikis Lithuania
Maria Madeleine Rüthrich Germany
Guy Williams United States
Magdalena Corona relative to Adolfo Sáez Spain Adolfo Sáez's profile →
Citations per field
00.5×6.3×
Adolfo Sáez · 1×
Citations per year

Countries citing papers authored by Magdalena Corona

Since Specialization
Citations

This map shows the geographic impact of Magdalena Corona's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Magdalena Corona with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Magdalena Corona more than expected).

Fields of papers citing papers by Magdalena Corona

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Magdalena Corona. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Magdalena Corona. The network helps show where Magdalena Corona may publish in the future.

Co-authorship network of co-authors of Magdalena Corona

This figure shows the co-authorship network connecting the top 25 collaborators of Magdalena Corona. A scholar is included among the top collaborators of Magdalena Corona based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Magdalena Corona. Magdalena Corona is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
#WorkIndexed citations
1 4
2 0
3 6
4 1
5 1
6 0
7 3
8 1
9 7
10 1
11 2
12 1
13 5
14 13
15 1
16 23
17 96
18 17

About Magdalena Corona

Magdalena Corona is a scholar working on Hematology, Infectious Diseases and Oncology, having authored 18 papers that have together received 182 indexed citations. Recurring topics across this work include CAR-T cell therapy research (7 papers), SARS-CoV-2 and COVID-19 Research (6 papers) and COVID-19 Clinical Research Studies (6 papers). The work is most often cited by research in Infectious Diseases (117 citations), Oncology (101 citations) and Hematology (21 citations). Magdalena Corona has collaborated with scholars based in Spain, United States and Greece. Frequent co-authors include Adolfo Sáez, Jesús Fortün, Carlota García‐Hoz, Pilar Herrera, Carlos Jiménez, Javier López‐Jiménez, Fernando Martín‐Moro, Juan Marquet, Irene García and Miguel Piris‐Villaespesa. Their work appears in journals such as Blood, PLoS ONE and Frontiers in Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026